Sign in
8-K

Current Report

Niagen Bioscience, Inc. Filed Acc 0001415889-16-006525

Bylaws or fiscal year change

  • Item 5.03 Amendments to articles or bylaws; change in fiscal year

From the SEC's structured data for this filing

Loading cdxc8k_july142016.htm…